A recent study also revealed that lncRNA AC026401.3 interacts with OCT1 to intensify sorafenib and lenvatinib resistance by activating E2F2 signaling in hepatocellular carcinoma [51]. The gene discussed is POU2F1; the disease is hepatocellular carcinoma.